Optiver Holding’s Day One Biopharmaceuticals DAWN Stock Holding History

Optiver Holding’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32	Closed	-$686	–	2841
2026 Q1	$686	Sell	32 -260	-89%	-$3.66K	﹤0.01%	2121
2025 Q4	$2.72K	Sell	292 -720	-71%	-$6.01K	﹤0.01%	1820
2025 Q3	$7.13K	Buy	+1,012	New	+$6.96K	﹤0.01%	1503

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Optiver Holding's DAWN Position: Q2 2026 in Review

Optiver Holding sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 32 shares — an estimated $686 sold.

Optiver Holding first reported a position in DAWN in Q3 2025 and held it in 3 quarters. The position peaked at $7.13K in Q3 2025. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Optiver Holding reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Optiver Holding sold 32 Day One Biopharmaceuticals shares in Q2 2026, an estimated $686.
Optiver Holding first reported a position in Day One Biopharmaceuticals in Q3 2025 and held it in 3 quarters.
Optiver Holding's Day One Biopharmaceuticals position peaked at $7.13K in Q3 2025.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.